Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63320	355	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
63185	Roche also wonders wtf is up with the FDA. Meanwhile, Laura Loomer is on a crusa	ghettogoulash	3	July 24
63184	Preceding that, more fake news: [graphic][graphic][graphic]	ghettogoulash	1	July 24
63183	found this hitting the wire at 3:22 Endpoints News Biotech/Pharma Reporter Zac	luckydog88	2	July 24
63182	Added more SRPT a little while ago in the mid-10's. But I was afraid to buy	Olecranon	-	July 24
63181	SRPT: talk about a divergence of analyst opinions this morning ........ Citigr	luckydog88	1	July 24
63180	Interesting that Goldman Sachs just downgraded IOVA (to $1.00), we all remember	Stikkmann	1	July 24
63179	Anyone following IOVA? Seems to be moving with good volume. Thoughts? TIA	CFL Invest 1	1	July 22
63178	I wasn't crazy about Sarepta defying FDA brass, but I could see why they did	ghettogoulash	1	July 22
63177	CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (SRPT) , the lead	luckydog88	-	July 21
63176	Don't know much about RFK, but his recent comments do not seem threatening,	ghettogoulash	-	July 21
63175	Elevedis is in ambulatory patients has quickly jumped over PMO as SRPT’s greates	Olecranon	-	July 21
63174	certainly looks like RFK is out to get them, whether it is deserved in some case	luckydog88	1	July 21
63173	This doesn't look like good news: investorrelations.sarepta.com Excerpts:	erickerickson	-	July 21
63172	Sarepta issues letter to Duchenne community: share.google	ghettogoulash	3	July 19
63171	Dr. Marty Makary, the F.D.A. commissioner, said in the agency’s statement that i	ghettogoulash	1	July 19
63170	There was a plea today on STAT news from two activist mothers of Duchenne patien	ghettogoulash	2	July 18
63169	CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (SRPT) , the lead	luckydog88	1	July 18
63168	FDA was already aware of the patient death in the Phase 1 trial of SRP-9004. Sar	ghettogoulash	1	July 18
63167	I juat assumed they knew it yesterday. Probably knew it for weeks or a month.	Olecranon	-	July 18
63166	They knew this yesterday during conference call: Exclusive-US FDA to ask Sarept	TripleE3	-	July 18
63165	BRIEF-Sarepta Says 51-Year-Old Male Patient Died In Early Stage Study Of SRP-900	luckydog88	-	July 18
63164	agreed - sold the extra I bought this morning, guess I own enough already. just	luckydog88	-	July 18
63163	This may be a case of don't try to catch a falling knife....	Davidoff	1	July 18
63162	wow - $14 and change pre-market ....... fingers crossed ..... just bought some	luckydog88	-	July 18
63161	SRPT 3rd Death from Liver Toxicity A month ago?! After yesterday's confere	TripleE3	-	July 18

Go to reply# or date (mm/dd/yy):